Liquid Biotech
Philadelphia, Pennsylvania, United States
About Liquid Biotech
Liquid Biotech is a developer of non-invasive blood tests for cancer. With the company's method, serial biopsies can be performed with little risk, live cancer cells can be isolated, and the genetic information from those cells can be used by the oncologist to guide therapy (personalized medicine). Cancer diagnosis and prognosis, as well as the emergence of therapeutic resistance mechanisms, are just a few of the many topics covered by Liquid Biotech's technology.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Dec 2015)
- Website: liquidbiotechusa.com
Industries & Categories
Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/liquid-biotech-2535902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.